Qx Therapeutics Inc. is a drug research and development company aiming to provide innovative treatment toward unmet medical needs in the acute lung injury (ALI) or Acute Respiratory Distress Syndrome (ARDS) disease area.
about us
Qx Therapeutics Inc., founded in 2017, is a Delaware corporation operating in Connecticut, US.
TECHNOLOGY
The technology is applicable to treatment of lung injuries caused by a wide ranges of insults
PIPELINE
QXT-101 is a first in class treatment for Acute Lung Injury (ALI) patients.
